Hints and tips:
Related Special Reports
...Pfizer said its approach was to seek opportunities “where we have the ability to add substantial value to rapidly bring new breakthroughs to patients”....
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...Some users of Medicare, the US government-funded insurance programme for seniors, will be able to access weight-loss drugs if they suffer from certain conditions such as cardiovascular disease, officials...
...Sistani made waves in the weight management industry last year with an acquisition that took the company Jean Nidetch launched in 1963 to run weight-loss support groups into the business of dispensing anti-obesity...
...In February’s mid-stage trials, Eli Lilly’s weight loss drug tirzepatide showed promise against MASH....
...They include the popular new diabetes and weight-loss drugs Ozempic and Wegovy, made by Novo Nordisk, and Mounjaro and Zepbound made by Eli Lilly....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...and dramatic weight-loss results boosting demand....
...The market for weight-loss drugs is projected to grow to $100bn by 2030, according to Goldman Sachs....
...loss drugs....
...This is creating an “urgent need” for policies to promote prevention, encourage weight loss and cut disease risks, says the paper published on Thursday in The Lancet....
...Ricks said Lilly contracted at least one of the three sites purchased by Novo Nordisk to fill its own weight-loss injection pens....
...And weight loss drugs like Ozempic have been in the news a lot. But are we missing their true potential?...
...The US pharma group was, perhaps, just trying to get ahead of the inevitable attention that weight-loss medicines would receive amid the Oscars glitz....
...But compared with other major investments, scientific breakthroughs come cheap....
...But in my case, the only clinical issue I have around my weight is, well, my weight. That and a psychological condition which makes dieting seem such a bore....
...“This new agent is the most efficacious of the [weight-loss drugs] we have seen so far,” she said....
...Going online spares blushes: not for nothing is there a focus on the likes of baldness, weight loss, erectile dysfunction and sexually transmitted diseases....
...And it’s not only companies in the weight-loss business that are being affected....
...Novo Nordisk’s weight-loss drug Wegovy cut the risk of death by 18 per cent in a trial that the Danish pharmaceutical company hopes will convince more health systems and insurers to pay for the treatment...
...For these reasons, the so-called Edmonton Obesity Staging System, which prioritises weight loss for those with severe obesity, is gaining a medical following....
...Danish drugmaker Novo Nordisk developed semaglutide, branded as Ozempic for people with diabetes and Wegovy for weight loss....
...The first real breakthrough came 14 years ago, when the drugmaker got its first approval for a GLP-1 drug for diabetes in 2009. Another version followed in 2015, targeting weight loss....
...Health effects After decades of drugs that either offered lacklustre weight loss, or serious side effects, semaglutide was a breakthrough for the treatment of obesity....
International Edition